536 related articles for article (PubMed ID: 18768571)
1. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.
Jann S; Bramerio MA; Facchetti D; Sterzi R
J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):70-3. PubMed ID: 18768571
[TBL] [Abstract][Full Text] [Related]
2. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Haq RU; Pendlebury WW; Fries TJ; Tandan R
Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
[TBL] [Abstract][Full Text] [Related]
3. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
Jann S; Beretta S; Bramerio MA
Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
[TBL] [Abstract][Full Text] [Related]
4. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammatory demyelinating polyneuropathy and respiratory failure.
Henderson RD; Sandroni P; Wijdicks EF
J Neurol; 2005 Oct; 252(10):1235-7. PubMed ID: 15940387
[TBL] [Abstract][Full Text] [Related]
8. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
9. Sensory CIDP presenting as cryptogenic sensory polyneuropathy.
Chin RL; Latov N; Sander HW; Hays AP; Croul SE; Magda P; Brannagan TH
J Peripher Nerv Syst; 2004 Sep; 9(3):132-7. PubMed ID: 15363060
[TBL] [Abstract][Full Text] [Related]
10. Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy.
Sharma KR; Cross J; Ayyar DR; Martinez-Arizala A; Bradley WG
Arch Neurol; 2002 May; 59(5):751-7. PubMed ID: 12020256
[TBL] [Abstract][Full Text] [Related]
11. Demyelinating neuropathy in diabetes mellitus.
Sharma KR; Cross J; Farronay O; Ayyar DR; Shebert RT; Bradley WG
Arch Neurol; 2002 May; 59(5):758-65. PubMed ID: 12020257
[TBL] [Abstract][Full Text] [Related]
12. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.
Stewart JD; McKelvey R; Durcan L; Carpenter S; Karpati G
J Neurol Sci; 1996 Oct; 142(1-2):59-64. PubMed ID: 8902721
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study.
Echaniz-Laguna A; de Séze J; Chanson JB
J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):699-705. PubMed ID: 22577230
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS;
Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854
[TBL] [Abstract][Full Text] [Related]
15. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
Busby M; Donaghy M
J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
[TBL] [Abstract][Full Text] [Related]
16. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
17. [Chronic inflammatory demyelinating polyneuropathy].
Köller H; Kieseier BC; Jander S; Hartung HP
Nervenarzt; 2003 Apr; 74(4):320-33. PubMed ID: 12707701
[TBL] [Abstract][Full Text] [Related]
18. Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Boukhris S; Magy L; Khalil M; Sindou P; Vallat JM
J Neurol Sci; 2007 Mar; 254(1-2):33-8. PubMed ID: 17286985
[TBL] [Abstract][Full Text] [Related]
19. Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy: clinical features and pathological study of the sural nerves.
Ohkoshi N; Harada K; Nagata H; Yato M; Shoji S
Eur Neurol; 2001; 45(4):241-8. PubMed ID: 11385262
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.
Kaplan A; Brannagan TH
Muscle Nerve; 2017 Apr; 55(4):476-482. PubMed ID: 27463215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
